Why IBM, GNC Holdings, and Intrexon Slumped Today – Motley Fool
Madison.com |
Why IBM, GNC Holdings, and Intrexon Slumped Today
Motley Fool The synthetic biology specialist announced that it had closed its secondary offering of stock to investors, selling 6.9 million shares of common stock at $12.50 per share. That price was more than 12% below the stock’s price as of Thursday evening … ValuEngine Lowers Intrexon (XON) to Strong SellThe Lincolnian Online Somewhat Positive News Coverage Somewhat Unlikely to Affect Intrexon (XON) Stock PriceStockNewsTimes |
|
Young Boy Becomes First DMD Patient to Receive Investigational Systemic Microdystrophin Gene Therapy
Muscular Dystrophy News The first Duchenne muscular dystrophy (DMD) patient has received systemic microdystrophin gene therapy as part of a Phase 1/2 clinical trial at Nationwide Children’s Hospital in Columbus, Ohio. The trial (NCT03375164), currently recruiting participants … |
|
Protein designed entirely from scratch functions in cells as a genuine enzyme
Science Daily Researchers are on the cusp of a true synthetic biology, Hecht said. “E. coli has 4,000 different genes,” he said. “We didn’t test all 4,000, because the only way this experiment works is if nothing grows on minimal medium, and of the 4,000, that’s … |
Science Daily |
Researchers create first stem cells using CRISPR genome activation
Science Daily These proteins, called transcription factors, work by changing which genes are expressed in the cell, turning off genes associated with skin cells and turning on genes associated with stem cells. Building on this work, Ding and others previously … How ‘stem cell‘ clinics became a Wild West for dodgy treatmentsNew Scientist Stem cells could help penis, breast and bottom enlargement | Daily …Daily Mail Men could soon make their penises bigger with liposuction and stem cell surgeryMetro Genetic Engineering & Biotechnology News –EurekAlert (press release) all 61 news articles » |